Zymeworks: To File Applications Seeking Regulatory Permission to Commence Clinical Studies for ZW171 in Other Non-US Jurisdictions in H2 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.